Why OVID Stock Might Be the Better for Long-Term Investors
OVID stock is gaining attention as a potential long-term biotech play, and for good reason. While not everyone’s radar is tuned into this name just yet, those who know the industry are starting to take note. The biotech world is full of swings and speculation—but OVID Therapeutics has something many others don’t: potential that’s rooted…